Zepzelca is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How do you pay?

How to pay the least

Given by your care team

Billed by the clinic

Zepzelca is given by a doctor or nurse, not picked up at a pharmacy.

  1. Ask your care team or your plan what you’d pay before your visit.

Compare every option

Question
Brand nameZepzelca
Authorized genericlurbinectedin
Regular genericlurbinectedin
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Zepzelca?
The original
–
–

Brand nameThe maker’s card

ZEPZELCA Savings Card (JazzCares)

Savings card from Jazz Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on jazzcares.com 

Or call 1-833-533-5299.

In the maker’s words

“Savings Card—If you are eligible and commercially insured, you may pay as little as $0 per prescription, subject to an annual maximum…”

From the maker’s offer on jazzcares.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Zepzelca itself, from the same company, sold without the brand name, and usually for less. For now Zepzelca is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ZEPZELCA is an alkylating drug indicated:

  • in combination with atezolizumab or atezolizumab and hyaluronidase-tqjs, for the maintenance treatment of adult patients with extensive-stage small cell lung cancer whose disease has not progressed after first-line induction therapy with atezolizumab or atezolizumab and hyaluronidase-tqjs, carboplatin and etoposide.

Source: the FDA label for Zepzelca (Jazz Pharmaceuticals, Inc.), September 30, 2026. Full label on DailyMed 

Good to know